A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study.
Consuming soy flour rich in the protein B-conglycinin has the potential to reduce LDL cholesterol levels and lower the risk of metabolic diseases such as atherosclerosis and fatty liver disease,
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Cholesterol | Fatty Liver Disease (FLD) | Liver | Liver Disease | Pharmaceuticals | Study | Urology & Nephrology